These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15713412)

  • 1. 2-substituted-4-aryl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-one as a structurally new NK1 antagonist.
    Seto S; Tanioka A; Ikeda M; Izawa S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1485-8. PubMed ID: 15713412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and evaluation of novel 2-substituted-4-aryl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,5]oxazocin-5-ones as NK1 antagonists.
    Seto S; Tanioka A; Ikeda M; Izawa S
    Bioorg Med Chem; 2005 Oct; 13(20):5717-32. PubMed ID: 15993086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel 9-substituted-7-aryl-3,4,5,6-tetrahydro-2H-pyrido[4,3-b]- and [2,3-b]-1,5-oxazocin-6-ones as NK(1) antagonists.
    Seto S; Tanioka A; Ikeda M; Izawa S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1479-84. PubMed ID: 15713411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of crucial structural requirements of 2-substituted pyrimido[4,5-b][1,5]oxazocines as NK(1) receptor antagonist by axially chiral derivatives.
    Seto S; Asano J
    Bioorg Med Chem; 2007 Aug; 15(15):5083-9. PubMed ID: 17540575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naphtho[2,1-b][1,5] and [1,2-f][1,4]oxazocines as selective NK1 antagonists.
    Ohnmacht CJ; Albert JS; Bernstein PR; Rumsey WL; Masek BB; Dembofsky BT; Koether GM; Andisik DW; Aharony D
    Bioorg Med Chem; 2004 May; 12(10):2653-69. PubMed ID: 15110847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a Bicyclic Pyrimidine Derivative (KRP-103), a Novel Selective Tachykinin NK1 Receptor Antagonist, on Bladder Function in Guinea Pigs.
    Tanioka A; Deguchi T
    Drug Res (Stuttg); 2017 May; 67(5):302-307. PubMed ID: 28268237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of dibenz[b,f][1,5]oxazocine derivatives for agonist activity at κ-opioid receptor.
    Mitra S; Banerjee TS; Hota SK; Bhattacharya D; Das S; Chattopadhyay P
    Eur J Med Chem; 2011 May; 46(5):1713-20. PubMed ID: 21392859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic urea derivatives as potent NK1 selective antagonists.
    Shue HJ; Chen X; Shih NY; Blythin DJ; Paliwal S; Lin L; Gu D; Schwerdt JH; Shah S; Reichard GA; Piwinski JJ; Duffy RA; Lachowicz JE; Coffin VL; Liu F; Nomeir AA; Morgan CA; Varty GB
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3896-9. PubMed ID: 16019209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of a new series of heterocyclic scaffolds for medicinal purposes.
    Hilal HS; Ali-Shtayeh MS; Arafat R; Al-Tel T; Voelter W; Barakat A
    Eur J Med Chem; 2006 Aug; 41(8):1017-24. PubMed ID: 16797790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Process development and large-scale synthesis of NK1 antagonist.
    Araya I; Kanazawa S; Akita H
    Chem Pharm Bull (Tokyo); 2008 Feb; 56(2):176-80. PubMed ID: 18239303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors.
    Rao AU; Xiao D; Huang X; Zhou W; Fossetta J; Lundell D; Tian F; Trivedi P; Aslanian R; Palani A
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1068-72. PubMed ID: 22182499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.
    Di Fabio R; Griffante C; Alvaro G; Pentassuglia G; Pizzi DA; Donati D; Rossi T; Guercio G; Mattioli M; Cimarosti Z; Marchioro C; Provera S; Zonzini L; Montanari D; Melotto S; Gerrard PA; Trist DG; Ratti E; Corsi M
    J Med Chem; 2009 May; 52(10):3238-47. PubMed ID: 19388677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
    Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
    Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles.
    Dawood KM; Abdel-Gawad H; Rageb EA; Ellithey M; Mohamed HA
    Bioorg Med Chem; 2006 Jun; 14(11):3672-80. PubMed ID: 16464601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic urea derivatives as potent NK1 selective antagonists. Part II: Effects of fluoro and benzylic methyl substitutions.
    Shue HJ; Chen X; Schwerdt JH; Paliwal S; Blythin DJ; Lin L; Gu D; Wang C; Reichard GA; Wang H; Piwinski JJ; Duffy RA; Lachowicz JE; Coffin VL; Nomeir AA; Morgan CA; Varty GB; Shih NY
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1065-9. PubMed ID: 16290143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthesis of new 7, 8 and 9-membered heterocyclic compounds containing oxygen and nitrogen as heteroatoms. III. Synthesis of new hexahydro-1,5-oxazocine derivatives with potential pharmacological activity].
    Glinka R; Kotelko B
    Acta Pol Pharm; 1976; 33(1):39-48. PubMed ID: 1266642
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel heterocyclic family of phenyl naphthothiazole carboxamides derived from naphthalimides: synthesis, antitumor evaluation, and DNA photocleavage.
    Li Z; Yang Q; Qian X
    Bioorg Med Chem; 2005 May; 13(9):3149-55. PubMed ID: 15809150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of bioactive polyheterocyclic ring systems as 5α-reductase inhibitors.
    Abdel Hafez NA; Farghaly TA; Al-Omar MA; Abdalla MM
    Eur J Med Chem; 2010 Nov; 45(11):4838-44. PubMed ID: 20739104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of 3,5-disubstituted benzamide analogues of DNK333 as dual NK1/NK2 receptor probes.
    Swarna VM; Undem BJ; Korlipara VL
    Bioorg Med Chem Lett; 2007 Feb; 17(4):890-4. PubMed ID: 17169559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.